Review



r d systems cat af1990  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems r d systems cat af1990
    R D Systems Cat Af1990, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/r d systems cat af1990/product/R&D Systems
    Average 94 stars, based on 10 article reviews
    r d systems cat af1990 - by Bioz Stars, 2026-05
    94/100 stars

    Images



    Similar Products

    94
    Sino Biological 10204 h02h sino biological cd103
    10204 H02h Sino Biological Cd103, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/10204 h02h sino biological cd103/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    10204 h02h sino biological cd103 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    90
    Boster Bio cd103
    Cd103, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd103/product/Boster Bio
    Average 90 stars, based on 1 article reviews
    cd103 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    86
    Cell Marque cd103
    Cd103, supplied by Cell Marque, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd103/product/Cell Marque
    Average 86 stars, based on 1 article reviews
    cd103 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    94
    Bio-Rad mca708 bio rad cd103
    Mca708 Bio Rad Cd103, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mca708 bio rad cd103/product/Bio-Rad
    Average 94 stars, based on 1 article reviews
    mca708 bio rad cd103 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    R&D Systems r d systems cat af1990
    R D Systems Cat Af1990, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/r d systems cat af1990/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    r d systems cat af1990 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    R&D Systems cd103
    Cd103, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd103/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    cd103 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    93
    Bio X Cell anti cd103
    Anti Cd103, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd103/product/Bio X Cell
    Average 93 stars, based on 1 article reviews
    anti cd103 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals cd103
    ( A ) Mel92.1 and MP41 cells were treated with DMSO, UNC0642 (1 μM), or A366 (1 μM) for 48 h and analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( B ) Mel92.1 and MP41 cells expressing either nonspecific (NS) shRNA or TGF-β1 shRNAs were analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( C ) Mel92.1 and MP41 cells expressing either an empty vector or V5-tagged TGF-β1 ORF were treated with DMSO or UNC0642 (1 μM) for 48 h and analyzed for the indicated protein using immunoblotting. ACTINB was used as a loading control. ( D ) Mel92.1 and MP41 cells expressing either NS shRNA, ULBP3 shRNAs, or MICB shRNAs were analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( E ) Mel92.1 and MP41 cells expressing either NS shRNA or MICB shRNAs were treated with DMSO or EHMT2 inhibitors UNC0642 (1 μM) for 48 h and were analyzed for NK cell-mediated cytotoxicity using an LDH-based cytotoxicity assay. Relative NK cell-mediated cytotoxicity under the indicated conditions are plotted. ( n = 6). P values were calculated using unpaired two-tailed Student’s t -test. ( F ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h followed by treated NK cells were used for NK cell-mediated cytotoxicity assay against Mel92.1 Cells. Relative NK cell-mediated cytotoxicity under indicated conditions are plotted. ( n = 6). P values were calculated using unpaired two-tailed Student’s t -test. ( G ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and were analyzed for IFN-γ mRNA levels using RT-qPCR. Relative IFN-γ mRNA levels are presented under the indicated conditions. ACTINB was used for normalization. ( n = 3). P values were calculated using unpaired two-tailed Student’s t -test. ( H ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for IFN-γ protein levels using ELISA. IFN-γ protein levels are presented under the indicated conditions. ( n = 3). P values were calculated using unpaired two-tailed Student’s t -test. ( I ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for EOMES and T-Bet protein levels using immunoblotting. ACTINB was used as a loading control. ( J ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for NCR3 and NKG2D protein using immunoblotting. ACTINB was used as a loading control. ( K ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for CD69, CD49a, <t>CD103,</t> CD56, and CXCR6 proteins using immunoblotting. ACTINB was used as a loading control. All quantitative data are shown as the mean ± SEM. .
    Cd103, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd103/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    cd103 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals nbp3 03545 rrid ab 3532135
    ( A ) Mel92.1 and MP41 cells were treated with DMSO, UNC0642 (1 μM), or A366 (1 μM) for 48 h and analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( B ) Mel92.1 and MP41 cells expressing either nonspecific (NS) shRNA or TGF-β1 shRNAs were analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( C ) Mel92.1 and MP41 cells expressing either an empty vector or V5-tagged TGF-β1 ORF were treated with DMSO or UNC0642 (1 μM) for 48 h and analyzed for the indicated protein using immunoblotting. ACTINB was used as a loading control. ( D ) Mel92.1 and MP41 cells expressing either NS shRNA, ULBP3 shRNAs, or MICB shRNAs were analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( E ) Mel92.1 and MP41 cells expressing either NS shRNA or MICB shRNAs were treated with DMSO or EHMT2 inhibitors UNC0642 (1 μM) for 48 h and were analyzed for NK cell-mediated cytotoxicity using an LDH-based cytotoxicity assay. Relative NK cell-mediated cytotoxicity under the indicated conditions are plotted. ( n = 6). P values were calculated using unpaired two-tailed Student’s t -test. ( F ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h followed by treated NK cells were used for NK cell-mediated cytotoxicity assay against Mel92.1 Cells. Relative NK cell-mediated cytotoxicity under indicated conditions are plotted. ( n = 6). P values were calculated using unpaired two-tailed Student’s t -test. ( G ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and were analyzed for IFN-γ mRNA levels using RT-qPCR. Relative IFN-γ mRNA levels are presented under the indicated conditions. ACTINB was used for normalization. ( n = 3). P values were calculated using unpaired two-tailed Student’s t -test. ( H ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for IFN-γ protein levels using ELISA. IFN-γ protein levels are presented under the indicated conditions. ( n = 3). P values were calculated using unpaired two-tailed Student’s t -test. ( I ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for EOMES and T-Bet protein levels using immunoblotting. ACTINB was used as a loading control. ( J ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for NCR3 and NKG2D protein using immunoblotting. ACTINB was used as a loading control. ( K ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for CD69, CD49a, <t>CD103,</t> CD56, and CXCR6 proteins using immunoblotting. ACTINB was used as a loading control. All quantitative data are shown as the mean ± SEM. .
    Nbp3 03545 Rrid Ab 3532135, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nbp3 03545 rrid ab 3532135/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    nbp3 03545 rrid ab 3532135 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Mel92.1 and MP41 cells were treated with DMSO, UNC0642 (1 μM), or A366 (1 μM) for 48 h and analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( B ) Mel92.1 and MP41 cells expressing either nonspecific (NS) shRNA or TGF-β1 shRNAs were analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( C ) Mel92.1 and MP41 cells expressing either an empty vector or V5-tagged TGF-β1 ORF were treated with DMSO or UNC0642 (1 μM) for 48 h and analyzed for the indicated protein using immunoblotting. ACTINB was used as a loading control. ( D ) Mel92.1 and MP41 cells expressing either NS shRNA, ULBP3 shRNAs, or MICB shRNAs were analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( E ) Mel92.1 and MP41 cells expressing either NS shRNA or MICB shRNAs were treated with DMSO or EHMT2 inhibitors UNC0642 (1 μM) for 48 h and were analyzed for NK cell-mediated cytotoxicity using an LDH-based cytotoxicity assay. Relative NK cell-mediated cytotoxicity under the indicated conditions are plotted. ( n = 6). P values were calculated using unpaired two-tailed Student’s t -test. ( F ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h followed by treated NK cells were used for NK cell-mediated cytotoxicity assay against Mel92.1 Cells. Relative NK cell-mediated cytotoxicity under indicated conditions are plotted. ( n = 6). P values were calculated using unpaired two-tailed Student’s t -test. ( G ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and were analyzed for IFN-γ mRNA levels using RT-qPCR. Relative IFN-γ mRNA levels are presented under the indicated conditions. ACTINB was used for normalization. ( n = 3). P values were calculated using unpaired two-tailed Student’s t -test. ( H ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for IFN-γ protein levels using ELISA. IFN-γ protein levels are presented under the indicated conditions. ( n = 3). P values were calculated using unpaired two-tailed Student’s t -test. ( I ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for EOMES and T-Bet protein levels using immunoblotting. ACTINB was used as a loading control. ( J ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for NCR3 and NKG2D protein using immunoblotting. ACTINB was used as a loading control. ( K ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for CD69, CD49a, CD103, CD56, and CXCR6 proteins using immunoblotting. ACTINB was used as a loading control. All quantitative data are shown as the mean ± SEM. .

    Journal: EMBO Molecular Medicine

    Article Title: Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression

    doi: 10.1038/s44321-025-00357-6

    Figure Lengend Snippet: ( A ) Mel92.1 and MP41 cells were treated with DMSO, UNC0642 (1 μM), or A366 (1 μM) for 48 h and analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( B ) Mel92.1 and MP41 cells expressing either nonspecific (NS) shRNA or TGF-β1 shRNAs were analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( C ) Mel92.1 and MP41 cells expressing either an empty vector or V5-tagged TGF-β1 ORF were treated with DMSO or UNC0642 (1 μM) for 48 h and analyzed for the indicated protein using immunoblotting. ACTINB was used as a loading control. ( D ) Mel92.1 and MP41 cells expressing either NS shRNA, ULBP3 shRNAs, or MICB shRNAs were analyzed for the indicated proteins using immunoblotting. ACTINB was used as a loading control. ( E ) Mel92.1 and MP41 cells expressing either NS shRNA or MICB shRNAs were treated with DMSO or EHMT2 inhibitors UNC0642 (1 μM) for 48 h and were analyzed for NK cell-mediated cytotoxicity using an LDH-based cytotoxicity assay. Relative NK cell-mediated cytotoxicity under the indicated conditions are plotted. ( n = 6). P values were calculated using unpaired two-tailed Student’s t -test. ( F ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h followed by treated NK cells were used for NK cell-mediated cytotoxicity assay against Mel92.1 Cells. Relative NK cell-mediated cytotoxicity under indicated conditions are plotted. ( n = 6). P values were calculated using unpaired two-tailed Student’s t -test. ( G ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and were analyzed for IFN-γ mRNA levels using RT-qPCR. Relative IFN-γ mRNA levels are presented under the indicated conditions. ACTINB was used for normalization. ( n = 3). P values were calculated using unpaired two-tailed Student’s t -test. ( H ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for IFN-γ protein levels using ELISA. IFN-γ protein levels are presented under the indicated conditions. ( n = 3). P values were calculated using unpaired two-tailed Student’s t -test. ( I ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for EOMES and T-Bet protein levels using immunoblotting. ACTINB was used as a loading control. ( J ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for NCR3 and NKG2D protein using immunoblotting. ACTINB was used as a loading control. ( K ) NK92MI cells were treated with TGF-β1 (10 ng/ml) for 24 h and analyzed for CD69, CD49a, CD103, CD56, and CXCR6 proteins using immunoblotting. ACTINB was used as a loading control. All quantitative data are shown as the mean ± SEM. .

    Article Snippet: CD103 (Diluted at 1:1000 for WB) , Novus Biologicals , NBP3-03545 RRID: AB_3532135.

    Techniques: Western Blot, Control, Expressing, shRNA, Plasmid Preparation, LDH Cytotoxicity Assay, Two Tailed Test, Cytotoxicity Assay, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay